This latest deep dive shifts focus from the assembly of proteins to their relentless, highly regulated breakdown. Protein degradation is a continuous, energy-spending process that occurs alongside synthesis to maintain cellular homeostasis. While it might seem counterintuitive to spend energy destroying what was just built, this system allows the body to selectively remove damaged proteins and recycle 75–80% of amino acids to synthesize new ones. We explore the specialized "shredders" and "recycling centers" of the cell, and how hormones like insulin and glucagon act as the master switches for these pathways.

Topic Outline

• The Nature of Degradation and Turnover

◦ Understanding degradation as a well-regulated, energy-intensive process rather than a passive decay.

◦ The recycling of amino acids versus their catabolism into glucose or ketone bodies.

◦ Variations in protein half-life, from minutes for metabolic enzymes to several days for structural muscle proteins like myosin.

• The Ubiquitin-Proteasome System (The Shredder)

◦ How this system handles over 80% of protein breakdown, focusing on defective or short-lived proteins.

◦ The "tagging" mechanism: Using E1, E2, and E3 enzymes to attach a poly-ubiquitin chain via isopeptide bonds.

◦ The architecture of the 26S Proteasome, which recognizes the ubiquitin tag and feeds the protein into a catalytic core for destruction.

• The Lysosomal System (The Recycler)

◦ The role of autophagy in engulfing long-lived proteins and entire organelles using membranes derived from the ER.

◦ How the low pH (4.5–5.0) environment and cathepsin enzymes within the lysosome facilitate rapid protein denaturation and cleavage.

◦ Triggers for autophagy, including starvation, oxidative stress, and hypoxia.

• The Calpain System

◦ The specific role of calcium-activated proteases in muscle tissue.

◦ How calpains perform the initial breakdown of myofibrils into smaller fragments for further degradation by the proteasome.

• Hormonal Regulation of Turnover

◦ Insulin as an Anabolic Shield: How it increases synthesis while simultaneously blocking FoxO transcription factors to reduce degradation.

◦ Growth Hormone (GH) and IGF-1: The long-term stimulation of translational efficiency and the necessity of insulin for GH to be effective.

◦ Catabolic Triggers: How Glucagon increases lysosomal activity and Corticosterone (Stress) ramps up the ubiquitin-proteasome system.

• Case Study: GH and Insulin Synergy

◦ An analysis of research on nursery pigs showing that GH significantly enhances protein synthesis in the fed state (with insulin) but fails to do so during fasting.

◦ The molecular explanation: Increased translational efficiency through better mRNA activation and initiation factor phosphorylation.